- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/06 - Antibacterial agents for tuberculosis
Patent holdings for IPC class A61P 31/06
Total number of patents in this class: 1397
10-year publication summary
|
66
|
61
|
88
|
87
|
100
|
79
|
72
|
105
|
81
|
48
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
45 |
| King Faisal University | 933 |
36 |
| Janssen Pharmaceutica N.V. | 3161 |
26 |
| Janssen Sciences Ireland Unlimited Company | 375 |
22 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
21 |
| Council of Scientific & Industrial Research | 1448 |
18 |
| Rutgers, The State University of New Jersey | 1977 |
14 |
| The Global Alliance for TB Drug Development, Inc. | 42 |
11 |
| Otsuka Pharmaceutical Co., Ltd. | 1506 |
11 |
| The Johns Hopkins University | 5907 |
9 |
| Agency for Science, Technology and Research | 3744 |
9 |
| Bioversys AG | 80 |
9 |
| Tecnimede Sociedade Tecnico-medicinal S.A. | 50 |
8 |
| The Board of Trustees of the Leland Stanford Junior University | 6678 |
7 |
| The Broad Institute, Inc. | 1983 |
7 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3267 |
7 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 187 |
7 |
| Longhorn Vaccines and Diagnostics, LLC | 92 |
7 |
| Nanyang Technological University | 2216 |
7 |
| University of Notre Dame du Lac | 610 |
7 |
| Other owners | 1109 |